0002007317-24-000382.txt : 20240311 0002007317-24-000382.hdr.sgml : 20240311 20240311165234 ACCESSION NUMBER: 0002007317-24-000382 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 24738839 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Neumann Mark CENTRAL INDEX KEY: 0001756211 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O INTRA-CELLULAR THERAPIES, INC. STREET 2: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 144 1 primary_doc.xml 144 0001756211 XXXXXXXX LIVE 0001567514 Intra-Cellular Therapies, Inc. 001-36274 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344 Neumann Mark Officer common Merrill Lynch

75 Rockefeller Plaza New York NY 10019

7345 481496.73 96807191 03/11/2024 NASDAQ COMMON 03/10/2022 COMPENSATION MARK NEUMANN N 7345 03/11/2024 COMPENSATION N MARK NEUMANN

430 EAST 29TH STREET NEW YORK NY 10016

COMMON 03/07/2024 13132 873367.79 MARK NEUMANN

430 EAST 29TH STREET NEW YORK NY 10016

COMMON 02/26/2024 7907 554008.86 MARK NEUMANN

430 EAST 29TH STREET NEW YORK NY 10016

COMMON 02/02/2024 11860 795670.96 03/11/2024 03/14/2023 MARK NEUMANN